Medical Weight Loss Treatment for Pennsylvania Residents
Medically Supervised Weight Loss, Delivered Online
Our providers are licensed by the Pennsylvania State Board of Medicine for comprehensive telehealth services statewide.
Whether you're in Philadelphia, Harrisburg, or anywhere across Pennsylvania — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Pennsylvania
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
The Keystone State connects America—and OmniRx Health connects Pennsylvanians with quality care. From Philadelphia's historic streets to Pittsburgh's tech revival, the Amish country of Lancaster to the wilds of the Poconos, we serve the entire Commonwealth. Our telehealth platform is ideal for busy professionals in the cities, rural residents far from specialists, and everyone in between who values convenient, quality healthcare without the hassle of traditional appointments.
Available Treatments in Pennsylvania
Our board-certified providers in Pennsylvania can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Pennsylvania
State Licensing
Our providers are licensed by the Pennsylvania State Board of Medicine for comprehensive telehealth services statewide.
Telehealth Law
Pennsylvania has comprehensive telehealth laws that support virtual care while maintaining quality and safety standards.
Pharmacy Access
Pennsylvania's extensive pharmacy network from Philadelphia to Pittsburgh and throughout rural areas ensures prescription access.
Insurance Notes
Pennsylvania requires telehealth coverage, with commercial insurers and Medicaid providing virtual visit benefits.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Pennsylvania
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.